focus -WSS

focus

author：fashion 2025-09-30 00:49:09 - browse：76256

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Ultragenyx gene therapy for rare liver ailment succeeds in late

leisure time

WSS

STAT wants to know your pick for a great summer read or listen

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

BMI, flaws aside, is found to be useful estimate of body fat in youth

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Woman returns to dialysis after doctors remove transplanted pig kidney

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Medical leaders decry Supreme Court decision on affirmative action

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Sports medicine is finally prioritizing gender equality

A letter from the executive editor: The 2023 STATUS List

Dobbs anniversary: the lost opportunity of abortion as health care

Security flaws in third

Sports medicine is finally prioritizing gender equality

Ultragenyx gene therapy for rare liver ailment succeeds in late

Activists slam private health insurers over coverage restrictions

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Wikipedia

The wait for US passports is creating travel purgatory and snarling summer plans

A letter from the executive editor: The 2023 STATUS List

The Pandemic Treaty must support building strong health systems

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Undocumented workers face uncertainty as immigration law takes effect in Florida

Canadians with cystic fibrosis outlive Americans by a decade

entertainment

Wikipedia

leisure time

Wikipedia